ANET Q1 2026 Earnings EPS Beats Estimates by Nearly 6 Stock Climbs ABUS Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline IBRX Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Focuses on Pipeline Progress Marker Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Progresses Western Copper and Gold Corporation WRN Q1 2026 Earnings EPS Misses Estimates as Development Costs Continue CWAN Q1 2026 Earnings Slight EPS Miss Amid Steady Operations